Roland GREINWALD

Person

Kenzingen, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Use of nor-ursodeoxycholic acid for reducing liver fat
- Patent number 11,850,252
- Issue date Dec 26, 2023
- Dr. Falk Pharma GmbH
- Markus Pröls
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation for the treatment of inflammatory change...
- Patent number 11,738,032
- Issue date Aug 29, 2023
- Dr. Falk Pharma GmbH
- Rudolph Wilhelm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized pharmaceutical formulation for the treatment of inflammat...
- Patent number 11,382,860
- Issue date Jul 12, 2022
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pellets having a multi-layer structure for delayed release of the a...
- Patent number 11,173,121
- Issue date Nov 16, 2021
- Dr. Falk Pharma GmbH
- Rudolf Wilhelm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized high-dose mesalazine-containing tablet
- Patent number 11,135,159
- Issue date Oct 5, 2021
- Dr. Falk Pharma GmbH
- Rudolph Wilhelm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulation for the treatment of inflammatory change...
- Patent number 10,905,699
- Issue date Feb 2, 2021
- Dr. Falk Pharma GmbH
- Rudolph Wilhelm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized pharmaceutical formulation for the treatment of inflammat...
- Patent number 10,695,291
- Issue date Jun 30, 2020
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized pharmaceutical formulation for the treatment of inflammat...
- Patent number 10,369,100
- Issue date Aug 6, 2019
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized pharmaceutical formulation for the treatment of inflammat...
- Patent number 9,867,780
- Issue date Jan 16, 2018
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHY...
- Publication number 20250041228
- Publication date Feb 6, 2025
- Dr. Falk Pharma GmbH
- Rudolf Wilhelm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORODISPERSIBLE EFFERVESCENT TABLET COMPRISING BUDESONIDE FOR USE IN...
- Publication number 20240238194
- Publication date Jul 18, 2024
- Dr. Falk Pharma GmbH
- Rudolf WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...
- Publication number 20230364113
- Publication date Nov 16, 2023
- Dr. Falk Pharma GmbH
- Rudolph WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED DISEASES
- Publication number 20230165845
- Publication date Jun 1, 2023
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC DISEASE
- Publication number 20230165844
- Publication date Jun 1, 2023
- Dr. Falk Pharma GmbH
- Roland Greinwald
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PELLETS HAVING A MULTI-LAYER STRUCTURE FOR DELAYED RELEASE OF THE A...
- Publication number 20210228487
- Publication date Jul 29, 2021
- Dr. Falk Pharma GmbH
- Rudolf WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...
- Publication number 20210100819
- Publication date Apr 8, 2021
- Dr. Falk Pharma GmbH
- Rudolph WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...
- Publication number 20200337997
- Publication date Oct 29, 2020
- Dr. Falk Pharma GmbH
- Roland GREINWALD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Nor-Ursodeoxycholic Acid for Reducing Liver Fat
- Publication number 20200246357
- Publication date Aug 6, 2020
- Dr. Falk Pharma GmbH
- Markus PRÖLS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...
- Publication number 20190358155
- Publication date Nov 28, 2019
- Dr. Falk Pharma GmbH
- Roland GREINWALD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMISED HIGH-DOSE MESALAZINE-CONTAINING TABLET
- Publication number 20180311155
- Publication date Nov 1, 2018
- Dr. Falk Pharma GmbH
- Rudolph WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...
- Publication number 20180200268
- Publication date Jul 19, 2018
- Dr. Falk Pharma GmbH
- Rudolph WILHELM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...
- Publication number 20180185277
- Publication date Jul 5, 2018
- Dr. Falk Pharma GmbH
- Roland GREINWALD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...
- Publication number 20160324772
- Publication date Nov 10, 2016
- Dr. Falk Pharma GmbH
- Roland GREINWALD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Roland GREINWALD

Person

Patents Grantslast 30 patents

Use of nor-ursodeoxycholic acid for reducing liver fat

Pharmaceutical formulation for the treatment of inflammatory change...

Optimized pharmaceutical formulation for the treatment of inflammat...

Pellets having a multi-layer structure for delayed release of the a...

Optimized high-dose mesalazine-containing tablet

Pharmaceutical formulation for the treatment of inflammatory change...

Optimized pharmaceutical formulation for the treatment of inflammat...

Optimized pharmaceutical formulation for the treatment of inflammat...

Optimized pharmaceutical formulation for the treatment of inflammat...

Patents Applicationslast 30 patents

ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHY...

ORODISPERSIBLE EFFERVESCENT TABLET COMPRISING BUDESONIDE FOR USE IN...

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...

SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED DISEASES

SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC DISEASE

PELLETS HAVING A MULTI-LAYER STRUCTURE FOR DELAYED RELEASE OF THE A...

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...

OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...

Use of Nor-Ursodeoxycholic Acid for Reducing Liver Fat

OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...

OPTIMISED HIGH-DOSE MESALAZINE-CONTAINING TABLET

PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMATORY CHANGE...

OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...

OPTIMIZED PHARMACEUTICAL FORMULATION FOR THE TREATMENT OF INFLAMMAT...